Eligibility-Criteria (29)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NSE will not issue new F&O contracts for HUDCO, Piramal Pharma, Tata Technologies, and Torrent Power after existing contract months expire. … | |||||||||||||||
NSE will not issue new F&O contracts for HUDCO, Piramal Pharma, Tata Technologies, and Torrent Power after existing contract months expire. All contracts in these securities will cease from April 29, 2026.
| |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to the Main Board and companies listed on other recognized stock exchanges … | |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to the Main Board and companies listed on other recognized stock exchanges seeking direct listing on the Main Board, covering paid-up capital, market capitalisation, liquidity, profitability, networth, and promoter holding requirements.
| |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to Main Board and companies listed on other recognized stock exchanges seeking … | |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to Main Board and companies listed on other recognized stock exchanges seeking direct listing on the Main Board, covering capital, liquidity, profitability, and promoter holding requirements.
| |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to Main Board and companies listed on other recognized stock exchanges seeking … | |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to Main Board and companies listed on other recognized stock exchanges seeking direct listing on the Main Board, covering paid-up capital, market capitalisation, liquidity, profitability, and promoter holding requirements.
| |||||||||||||||
BSE revises eligibility criteria for SME companies seeking migration to Main Board and for companies listed on other recognized stock … | |||||||||||||||
BSE revises eligibility criteria for SME companies seeking migration to Main Board and for companies listed on other recognized stock exchanges seeking direct listing on the Main Board, covering paid-up capital, market capitalisation, liquidity, profitability, and promoter holding requirements.
| |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to Main Board and companies listed on other recognized stock exchanges seeking … | |||||||||||||||
BSE revises eligibility criteria for SME companies migrating to Main Board and companies listed on other recognized stock exchanges seeking direct listing on Main Board, covering paid-up capital, market capitalisation, liquidity, profitability, and promoter holding requirements.
| |||||||||||||||
BSE revises eligibility criteria for companies listed on other recognized stock exchanges seeking direct listing on Main Board, and for SME … | |||||||||||||||
BSE revises eligibility criteria for companies listed on other recognized stock exchanges seeking direct listing on Main Board, and for SME companies migrating to Main Board, covering paid-up capital, market cap, liquidity, profitability, and promoter holding requirements.
| |||||||||||||||
NSE announces discontinuation of new F&O contract months for SYNGENE INTERNATIONAL LIMITED effective April 01, 2026, while existing … | |||||||||||||||
NSE announces discontinuation of new F&O contract months for SYNGENE INTERNATIONAL LIMITED effective April 01, 2026, while existing contracts until March 2026 will continue trading.
| |||||||||||||||
Syngene International Ltd F&O contracts to be discontinued from March 27, 2026 as per SEBI eligibility criteria review. Existing contracts … | |||||||||||||||
Syngene International Ltd F&O contracts to be discontinued from March 27, 2026 as per SEBI eligibility criteria review. Existing contracts will expire on respective dates.
| |||||||||||||||
Syngene International Ltd derivatives contracts will be discontinued from March 27, 2026 with existing contracts expiring on their … | |||||||||||||||
Syngene International Ltd derivatives contracts will be discontinued from March 27, 2026 with existing contracts expiring on their respective dates through March 25, 2026.
| |||||||||||||||